Abstract:Key PointsAbout 10% of all cancers, including some that have a particularly poor prognosis, use the alternative lengthening of telomeres (ALT) pathway to prevent the telomere shortening that accompanies proliferation of normal cells.ALT-positive cells commonly have a number of unusual characteristics, including telomeric DNA that is separated from chromosome ends. This extrachromosomal telomeric DNA may be linear or circular.Partially single-stranded circles of telomeric DNA in which the C-rich (AATCCC)n strand is essentially intact and the G-rich (TTAGGG)n strand is gapped seem to be the best of the known markers for ALT. The quantity of this 'C-circle' DNA correlates well with the amount of ALT activity.Telomere elongation in ALT cells involves homologous recombination.The experimental evidence fits best with a model for ALT in which telomeric 3′ overhangs become extended by invading other telomeric DNA and using it as a template for DNA replication. The other telomeric DNA can be: part of the same telomere (through telomere-loop formation); in a sister chromatid; in the telomere of another chromosome; or in one of the forms of extrachromosomal telomeric DNA.Proteins that are thought to be required for ALT include the homologous recombination protein complexes MRN (which is made up of meiotic recombination 11 (MRE11, also known as MRE11A), RAD50 and Nijmegen breakage syndrome 1 (NBS1, also known as NBN)) and structural maintenance of chromosomes 5 (SMC5)–SMC6, and proteins, such as flap endonuclease 1 (FEN1), MUS81, Fanconi anaemia group D2 (FANCD2) and Fanconi anaemia group A (FANCA), that may be required for recombination-dependent restart of stalled telomeric DNA replication.Promyelocytic leukaemia (PML) bodies containing telomeric DNA are characteristic of ALT cells, and are referred to as ALT-associated PML bodies (APBs). Large APBs seem to be associated with senescence of ALT cells and sequestration of extrachromosomal DNA, but we speculate that smaller APBs may be sites at which telomere lengthening occurs.In ALT cells, many of the telomeres elicit a DNA-damage response but repress chromosome end-to-end fusions. This telomere state, which is intermediate between the fully capped and uncapped fusogenic telomere states, may reflect a structural change that is permissive for recombination-mediated telomere replication.

The alternative lengthening of telomeres mechanism jeopardizes telomere integrity if not properly restricted

TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells

Role of TERRA in the Regulation of Telomere Length

TERRA and the alternative lengthening of telomeres: a dangerous affair

Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks

Alternative Lengthening of Telomeres: DNA Repair Pathways Converge

Alternative Lengthening of Telomeres and Mediated Telomere Synthesis

Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)

Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends

Alternative lengthening of telomeres: models, mechanisms and implications

Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes

Telomeric transcripts stimulate telomere recombination to suppress senescence in cells lacking telomerase

Alternative Lengthening Of Telomeres In Htert-Inhibited Laryngeal Cancer Cells

Alternative Lengthening of Telomeres: Lessons to Be Learned from Telomeric DNA Double-Strand Break Repair

Molecular mechanisms of activity and derepression of alternative lengthening of telomeres

Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers

Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs

Brca2 abrogation engages with the alternative lengthening of telomeres via break‐induced replication

Alternative lengthening of telomeres in normal mammalian somatic cells